releases: https://sarbanes.house.gov/media-center/in-the-news/hhs-recommends-co-prescribing-naloxone-with-opioids
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://sarbanes.house.gov/media-center/in-the-news/hhs-recommends-co-prescribing-naloxone-with-opioids | HHS Recommends Co-Prescribing Naloxone with Opioids | 2018-12-20 | 2018 | 2018-12 | Democrat | House | MD | John Sarbanes | S001168 | sarbanes.house.gov | legacy | Congress also has addressed the co-prescribing issue. In 2016, the House passed theCo-Prescribing to Reduce Overdoses Actsponsored by Rep. John Sarbanes (D-Md.). The bill, which became part of the Comprehensive Addiction and Recovery Act, authorized 5 years of grants aimed at increasing co-prescribing of naloxone in high-risk patients who are prescribed opioids; however, funds were never appropriated for the grant program.... Sarbanes applauded the new HHS guidelines, calling them "an important and encouraging step forward in our fight against the opioid epidemic." ... "By getting more affordable and easy-to-use overdose reversal drugs into the hands of patients and communities across the country, we can save countless lives," he said in a press release issued Thursday. | 1 | 2026-03-30T12:14:52Z | 2026-03-30T12:14:52Z |